Finance

Beta
Lists
BDSX:NASDAQ
Biodesix Inc
20,19 $
+1,15%
(+0,23) 1D
17 шіл., 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BDSX...
Open
20,11 $
High
20,21 $
Low
19,48 $
Mkt. cap
209,08 млн
Avg. vol.
82,18 мың
Volume
40,80 мың
52-wk high
24,92 $
52-wk low
5,26 $
EPS
-4,03 $
Beta
0,53
Shares outstanding
10,36 млн
No. of employees
334
Open
20,11 $
High
20,21 $
Low
19,48 $
Mkt. cap
209,08 млн
Avg. vol.
82,18 мың
Volume
40,80 мың
52-wk high
24,92 $
52-wk low
5,26 $
EPS
-4,03 $
Beta
0,53
Shares outstanding
10,36 млн
No. of employees
334
News stories
From sources across the web
About Biodesix Inc
CEO-
Employees334
Founded2005
HeadquartersЛуйсвилл, Колорадо, Америка Құрама Штаттары
SectorHealth care provider
Websitebiodesix.com
Analyst ratings
Based on 7 analysts giving stock ratings to BDSX in the past 3 months
Strong buy
Buy
7
Hold
0
Sell
0
12-month forecast
Based on 7 Wall Street analysts offering 12 month price targets for BDSX in the last 3 months.
Highest
Current 20,19 $
40,00 $ (+98,12%)
Average
31,00 $ (+53,54%)
Lowest
26,00 $ (+28,78%)
Analyst
Recommendation
Action
Price target
Projected
Date
Max Masucci
Roth MKM
Buy
Initiated
32,00 $
+58,5%
06/25/2026
Unknown Analyst
Roth MKM
Buy
Initiated
32,00 $
+58,5%
06/24/2026
Kyle Mikson CFA
Canaccord Genuity
Buy
Reiterated
27,00 $
+33,7%
06/18/2026
Yi Chen
H.C. Wainwright
Buy
Initiated
26,00 $
+28,8%
06/15/2026
Daniel Brennan
TD Cowen
Buy
Reiterated
30,00 $
+48,6%
05/05/2026
William Bonello
Craig-Hallum
Buy
Maintained
-
-
05/05/2026
Thomas Flaten
Lake Street
Buy
Maintained
40,00 $
+98,1%
05/05/2026
Andrew Brackmann
William Blair
Buy
Maintained
-
-
05/05/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
2025 ж. мау.
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
Revenue
20,02 млн
21,77 млн
28,76 млн
25,56 млн
Cost of goods sold
4,03 млн
4,11 млн
4,88 млн
4,60 млн
Cost of revenue
4,03 млн
4,11 млн
4,88 млн
4,60 млн
Research and development expenses
3,27 млн
2,99 млн
2,87 млн
3,28 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
22,41 млн
21,71 млн
22,97 млн
24,26 млн
Operating expense
25,68 млн
24,71 млн
25,84 млн
27,55 млн
Total operating expenses
29,71 млн
28,81 млн
30,72 млн
32,15 млн
Operating income
-9,69 млн
-7,04 млн
-1,97 млн
-6,60 млн
Other non operating income
149,00 м.
409,00 м.
46,00 мың
385,00 м.
EBT including unusual items
-11,47 млн
-8,72 млн
-3,98 млн
-7,79 млн
EBT excluding unusual items
-11,44 млн
-8,71 млн
-3,98 млн
-8,19 млн
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-11,47 млн
-8,72 млн
-3,98 млн
-7,79 млн
Net profit margin
-57,29%
-40,04%
-13,84%
-30,50%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-1,90 млн
-2,07 млн
-2,06 млн
-1,98 млн
Net interest expenses
-1,90 млн
-2,07 млн
-2,06 млн
-1,98 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
-8,26 млн
-5,64 млн
-579,00 м.
-5,20 млн
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer